228 related articles for article (PubMed ID: 9405667)
1. Role of B cells in antigen presentation of the hepatitis B core.
Milich DR; Chen M; Schödel F; Peterson DL; Jones JE; Hughes JL
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14648-53. PubMed ID: 9405667
[TBL] [Abstract][Full Text] [Related]
2. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
4. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.
Lazdina U; Alheim M; Nyström J; Hultgren C; Borisova G; Sominskaya I; Pumpens P; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2003 Jan; 84(Pt 1):139-146. PubMed ID: 12533710
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis nucleocapsid as a vaccine carrier moiety.
Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
[TBL] [Abstract][Full Text] [Related]
8. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
9. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.
Milich DR; McLachlan A
Science; 1986 Dec; 234(4782):1398-401. PubMed ID: 3491425
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
11. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
13. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
Milich DR; McLachlan A; Moriarty A; Thornton GB
J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
[TBL] [Abstract][Full Text] [Related]
14. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice.
Lin YJ; Wu HL; Chen DS; Chen PJ
J Virol; 2012 Sep; 86(17):9266-73. PubMed ID: 22718814
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
[TBL] [Abstract][Full Text] [Related]
17. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
18. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
[TBL] [Abstract][Full Text] [Related]
19. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
20. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
